Shopping Cart
Remove All
Your shopping cart is currently empty
EPI-589, a quinone derivative and oxidoreductase enzyme inhibitor, is considered safe and well tolerated, showing promise for the treatment of amyotrophic lateral sclerosis (ALS).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | $46 | 5 days | 5 days |
| Description | EPI-589, a quinone derivative and oxidoreductase enzyme inhibitor, is considered safe and well tolerated, showing promise for the treatment of amyotrophic lateral sclerosis (ALS). |
| Targets&IC50 | Oxidoreductase enzyme: |
| In vivo | EPI-589 significantly enhances biomarkers in cerebrospinal fluid (CSF) and plasma associated with neuroinflammation and ALS disease progression. |
| Molecular Weight | 265.31 |
| Formula | C14H19NO4 |
| Cas No. | 1147883-03-1 |
| Relative Density. | 1.187 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.